← back to database
Avoro Ventures is the private-markets affiliate of Avoro Capital focused on development-stage biotechnology and breakthrough therapeutics. The firm participates in and can lead large life-sciences financings.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$186M Fund I
Latest fund vintage
2022
Investing team
Behzad AghazadehManaging Partner
Jenna GlatzerAssociate
Mark ChinInvestment Partner
Uya ChuluunbaatarInvestment Partner
How to reach them
Notable investments
Hemab Therapeutics, Ottimo Pharma, Vanqua Bio, Aadi Bioscience
Sources
avorocapital.com/team ↗avorocapital.com/investments ↗avorocapital.com/news/avoro-ventures-announces-final-close-of-inaugural-fund-and-adds-uya-chuluunbaatar-as-a-partner ↗avorocapital.com/news/scribe-therapeutics-raises-100m-series-b-financing-to-further-develop-crispr-by-design-platform-and-pipeline-of-breakthrough-genetic-medicines ↗